期刊文献+

致心律失常性右室心肌病的临床特征及预后因素 被引量:4

Clinical Features and Prognostic Factors of Arrhythmogenic Right Ventricular Cardiomyopathy
下载PDF
导出
摘要 致心律失常性右室心肌病又称致心律失常性右室发育不良,是一种右室心肌细胞被纤维/脂肪细胞取代,进而导致室性心律失常的遗传性心肌病。致心律失常性右室心肌病主要的发病人群以青少年为主,以年轻运动员最为多见。近些年随着医学水平的进步,对致心律失常性右室心肌病的临床特征和预后因素等方面的认识越来越深入。现就致心律失常性右室心肌病的临床特征及其预后因素进行综述,为致心律失常性右室心肌病的临床治疗提供帮助。 Arrhythmogenic right ventricular cardiomyopathy(ARVC),also known as arrhythmogenic right ventricular dysplasia,is a genetic cardiomyopathy of ventricular arrhythmia caused by the replacement of right ventricular myocytes by fibro/fatty cell. The main morbidity groups are adolescents,and the young athletes are the most common. In recent years,with the advancement of medical level,the clinical characteristics and prognostic factors of ARVC have become more and more in-depth. This article reviews the clinical features of ARVC and its prognostic factors,and provides assistance for the clinical treatment of ARVC.
作者 马慧慧 周咏梅 罗蓉 李小平 MA Huihui;ZHOU Yongmei;LUO Rong;LI Xiaoping(School of Medcine,University of Electronic Science and Technology of China,Department of Cardiology,Sichuan Provincial People’s Hospital,Chengdu 610072,Sichuan,China;Cardiovascular Research Institute of Chengdu Medical College,Chengdu 610500,Sichuan,China)
出处 《心血管病学进展》 CAS 2019年第2期272-276,共5页 Advances in Cardiovascular Diseases
基金 国家自然科学基金(81470521 81770379) 四川省科技厅基本科研业务项目(2017YSKY0001)
关键词 致心律失常性右室心肌病 临床特征 预后因素 Arrhythmogenic right ventricular cardiomyopathy Clinical features Prognostic factors
  • 相关文献

参考文献6

二级参考文献86

  • 1自发性高血压大鼠用各种降压药治疗时血压变异性、压力感受器反射敏感性与靶器官损害[J].中华高血压杂志,2007,15(1):38-38. 被引量:2
  • 2Somers VK,White DP, Amin R, et al. Sleep apnea and cardiovascular disease: An American Heart Association/American College of Cardiology Foundation Scientific Statement from the American Heart Association Council for High Blood Pressure Research Professional Education Committee, Council on Clinical Cardiology, Stroke Council, and Council on Cardiovascular Nursing[J]. J Am Coil Cardiol,2008.52(8) ,686-717.
  • 3Whitworth JA, World Health Organization, International Society of Hypertension Writing Group. 2003 World Health Organization (WHO)/International Society of Hypertension(ISH ) statement on management of hypertension(Guidelines and recommendations) [J]. J Hypertens,2003,21 :1983-1992.
  • 4中华人民共和国卫生部.中国高血压防治指南(2005年修订版)[M].2005:1-5.
  • 5Mancia G,Grassi G. Mechanisms and clinical implications of blood pressure variability [J]. J Cardiovasc Pharmacol, 2000, 35 ( Suppl 4):15-19.
  • 6Kikuya M, Hozawa A,Ohokuho T,et al. Prognostic significance of blood pressure and heart rate variabilities : The Ohasama study[J]. Hypertension, 2000,36 (5) : 901-906.
  • 7Dazai Y, Iwata T, Hiwada K. Augmentation of baroreceptor reflex function by oral calcium supplementation in essential hypertension[J]. Clin Exp Pharmacol Physiol,1994,21(3) :173-178.
  • 8Siche JP,Singere P,De Gandemaris R,et al. Variability in arterial blood pressure at rest depends in the sensitivity of the baroreflex [J]. J Hypertens,1993,11( Suppl 5) :s176-s177,.
  • 9Corrado D,Basso C,Pavei A,et al.Trends in suddencardiovascular death in young competitive athletes afterimplementation of a preparticipation screening program[J].JAMA,2006,296:1593-1601.
  • 10Peters S,Trummel M,Meyners W.Prevalence of rightventricular dysplasia-cardiomyopathy in a non-referralhospital[J].Int J Cardiol,2004,97:499-501.

共引文献11

同被引文献49

引证文献4

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部